DME Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

DME Capital Management’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-136,350	Closed	-$61.3K	–	45
2024 Q1	$61.3K	Buy	+136,350	New	+$103K	﹤0.01%	40

Other funds holding NBSE

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

DME Capital Management's NBSE Position: Q2 2024 in Review

DME Capital Management sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2024, closing a stake of 136,350 shares — an estimated $61.3K sold.

DME Capital Management first reported a position in NBSE in Q1 2024 and held it in 1 quarter. The position peaked at $61.3K in Q1 2024. 3 funds tracked by Wall St. Rank hold NBSE as of Q2 2024.

DME Capital Management reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
DME Capital Management sold 136,350 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $61.3K.
DME Capital Management first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
DME Capital Management's NeuBase Therapeutics, Inc. Common Stock position peaked at $61.3K in Q1 2024.
3 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2024.

Based on DME Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.